OR WAIT null SECS
August 02, 2017
Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.
July 02, 2017
New ADC therapies must overcome manufacturing challenges to reach market.
May 15, 2017
Catalent has signed an agreement with Therachon to support preclinical and clinical development of TA-46, a novel protein being developed to treat achondroplasia.
Prefilled dual-chamber cartridges offer several advantages. Several steps should be taken to determine if a dual-chamber system is viable for a lyophilized injectable drug product.
April 05, 2017
Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.
March 02, 2017
Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.
February 07, 2017
The investment will be used to advance Nemaura’s R&D programs, which include liquid vaccines that have been reformulated for administration through the skin using its micropatch drug delivery technology.
November 02, 2016
A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.
July 02, 2016
Aseptic spray drying provides an alternative to lyophilization as an enabling stabilization technology for parenteral biologic formulations.